Skip to content
Amsterdam UMC Websites
Healthcare
Nieuws & organisatie (NL)
News & corporate
Research
Emma Children's Hospital
Careers
Menu
Menu
Research
Research
NL
Nederlands
Search
Search
Amsterdam UMC Research
Conducting Research
Research Institutes
Research Institutes
Cancer Center Amsterdam
Amsterdam Cardiovascular Sciences
Amsterdam Gastroenterology Endocrinology Metabolism
Amsterdam Institute for Immunology and Infectious diseases
Amsterdam Movement Sciences
Amsterdam Neuroscience
Amsterdam Public Health
Amsterdam Reproduction & Development
Researchers
Researchers
All researchers
Careers at Amsterdam UMC
About Amsterdam UMC Research
About Amsterdam UMC Research
Organization
About Research Support
Supporting Committees
Departments
News
News
News
Research highlights
Events
Research Roadmap
Research Roadmap
Design & Preparation
Conduct & Collecting data
Closure, Publishing & Archiving
Core facilities
Core facilities
Biobank
CRISPR Center
Functional Genomic Screening
Genomics
Induced Pluripotent Stem Cells
Metabolomics
Microscopy and Cytometry
OncoProteomics
Research Imaging Core Center
Research Support
Research Support
Legal Research Support
Medical library
Methodological and statistical support
Research Code
Data Management
Grant Support
Policy Office
All support
Doctoral school
Doctoral school
Orientation
PhD trajectory
Contact
Career at Amsterdam UMC
About Amsterdam UMC
Contact
Career at Amsterdam UMC
About Amsterdam UMC
Other channels of
Amsterdam UMC
Healthcare
Nieuws & organisatie (NL)
News & corporate
Research
Emma Children's Hospital
Careers
Sluit menu
Search
Cancer Center Amsterdam
Navigate to
Home
Research
Researchers
Research highlights
Research programs
Research information
Research groups
News
Events
Grant information
Education
PhD candidates
BSc/MSc students
Postdocs
Partnering
About
Cancer Center Amsterdam
CCA News
New blood test offers better remission assessment for Large B-Cell Lymphoma patients
A large Dutch study validates that a simple blood test can more accurately identify which patients with Large B-Cell Lymphoma (LBCL) are at risk of relapse after treatment. Last week, these results been published in The Journal of Clinical Oncology
Grant of over 1 million euros awarded for research into new imaging technique for hormone-sensitive breast cancer
Medical oncologist Willemien Menke-van der Houven van Oordt has been awarded over 1 million euros in funding from KWF Kankerbestrijding to investigate a novel imaging technique for patients with locally advanced or recurrent hormone-sensitive (ER+) breast cancer.
Major KWF funding boost for innovative cancer research
KWF is investing over 8 million euros in Amsterdam UMC - Cancer Center Amsterdam to support 11 promising and innovative cancer research projects.
Subscribe to our Newsletter
Sign up
Archive
All news from Cancer Center Amsterdam
December 11, 2024
Compete in the Amsterdam Science & Innovation Award 2025
December 11, 2024
Nursing Symposium 2025 Best Poster Prize
December 11, 2024
Galapagos Announces Promising New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma
December 11, 2024
Identifying colorectal cancer-specific vulnerabilities in the Wnt-driven long non-coding transcriptome
December 4, 2024
Vote for the Amsterdam UMC Societal Impact Award 2024
November 29, 2024
KHMW thesis prize in interdisciplinarity 2025
November 29, 2024
Amsterdam UMC - Postdoc Career Bridging Grant
November 28, 2024
Advancing Gastric Cancer Surgery: The OMEGA Trial Seeks to Refine Gastric Cancer Surgery by Examining the Role of Omentum Preservation
November 28, 2024
PURE Amsterdam UMC available, please check your profile
November 28, 2024
Fewer side effects and costs through smart drug deployment in metastatic breast cancer
November 25, 2024
AUF Impact Call 2024: 8 times €25,000 for young researchers
November 20, 2024
PSMA-PET/CT before reaching the Phoenix criteria for biochemical recurrent prostatecancer: earlier detection of prostatecancer recurrences with improved outcomes
November 20, 2024
Cancer treatment response evaluation after only 2 weeks? Using 7 Tesla 31P MRSI of liver metastases to evaluate response to systemic treatment of gastric and esophageal cancer – early results of the MAESTRO study.
November 20, 2024
Start wave 13 in sight: about 700 colleagues are moving to RDC Adore
November 20, 2024
'Together with Flevo Hospital, we have been delivering the right care in the right place for 15 years'
November 20, 2024
The RADICES study: does a combination of exercise and diet improve quality of life in patients with incurable cancer of esophagus and stomach?
November 14, 2024
One PURE-system for all of Amsterdam UMC
November 7, 2024
Internship platform is live!
November 6, 2024
KWF awards 1.8 million euros to research inclusive care for incurably ill cancer patients
November 5, 2024
Researchers identify shield of cells that protects lung tumours from treatment
November 4, 2024
Valorization Compass to Increase Societal Impact
November 1, 2024
Optimizing Follow-up Care for Lung Cancer: Investigating PET/CT's Impact on Survival and Cost-effectiveness
October 29, 2024
Hallmarks of a genomically distinct subclass of head and neck cancer
October 29, 2024
Vidi for Cancer Center Amsterdam researcher Jochem Bernink
October 23, 2024
TCS Amsterdam Marathon: record amount of 1.3 million euros for cancer research
October 23, 2024
SPACETIME Project Kicks Off in Amsterdam: Unraveling Lung Tumors in Space and Time
October 21, 2024
Data & AI symposium on December 9: drivers of innovation in Amsterdam UMC
October 19, 2024
Inaugural lecture André N. Vis about an innovative, intelligent and inspiring approach to bladder and prostate cancer
October 10, 2024
[Video] Scientist Arjan Griffioen leads cancer treatment innovation with lab and startup
October 9, 2024
Partially outsourcing your care: 'BETER-poli fits better there'
1
2
3
4
5
6
7
8
9
10
11
12
Back to top
